HOMRE Ltd
HOMRE Ltd (HOM) is scheduled to report results on 16 Oct 2026. HOMRE Ltd last reported results for the quarter ended Jun 2026, with sales of ₹11.92 crore and net profit of ₹0.63 crore. The stock last traded at ₹1.94, a market capitalisation of ₹38.8 crore, on a P/E of 144. Over the past 52 weeks the stock has ranged between ₹1.15 and ₹3.47. Figures are as of 9 Oct 2026 and are not real time.
HOMRE Ltd share price and key metrics
- Current price
- ₹1.94
- Market cap
- ₹38.8 cr
- Stock P/E
- 144
- Book value
- ₹0.01
- ROE
- -6.78%
- ROCE
- 36.9%
- Dividend yield
- 0.00%
- 52w high / low
- 3.47/1.15
Metrics as of 9 Oct 2026. Not real time.
Track HOMRE Ltd
Cruxal reads every HOMRE Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
HOMRE Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- %
- 10 Years
- 7%
- 5 Years
- 14%
- 3 Years
- 24%
- TTM
- -25%
- 10 Years
- 20%
- 5 Years
- 44%
- 3 Years
- 72%
- 1 Year
- 52%
- 10 Years
- -11%
- 5 Years
- -20%
- 3 Years
- -38%
- Last Year
- -7%
HOMRE Ltd quarterly results
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 2.45 | 6.88 | 5.96 | 11.92 |
| Expenses | 0.04 | 0.05 | 0.26 | 0.13 | 2.47 | 6.6 | 5.37 | 11.54 |
| Operating profit | -0.04 | -0.05 | -0.26 | -0.13 | -0.02 | 0.28 | 0.59 | 0.38 |
| OPM % | — | — | — | — | -0.82% | 4.07% | 9.90% | 3.19% |
| Other income | 0 | 0 | 0.64 | 0.36 | 0.24 | 0.04 | -0.1 | 0.47 |
| Interest | 0.05 | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0.09 | -0.1 | 0.38 | 0.23 | 0.22 | 0.32 | 0.49 | 0.85 |
| Tax % | 0.00% | 0.00% | 0.00% | 26.09% | 22.73% | 25.00% | 253.06% | 24.71% |
| Net profit | -0.09 | -0.1 | 0.38 | 0.17 | 0.16 | 0.24 | -0.76 | 0.63 |
| EPS (₹) | -0.00 | -0.01 | 0.02 | 0.01 | 0.01 | 0.01 | -0.04 | 0.03 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
HOMRE Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15.29 | 27.21 |
| Operating profit | -0.22 | -0.25 | -0.18 | -0.43 | -0.31 | -0.23 | -0.2 | -0.26 | -0.42 | 0.7 | 1.23 |
| OPM % | — | — | — | — | — | — | — | — | — | 4.58% | 4.52% |
| Net profit | -9.74 | -0.1 | -10.05 | -0.83 | -1.44 | -2.5 | -0.19 | -0.44 | 0.08 | -0.02 | 0.27 |
| EPS (₹) | -0.49 | -0.01 | -0.50 | -0.04 | -0.07 | -0.13 | -0.01 | -0.02 | 0.00 | -0.00 | 0.01 |
TTM is the trailing twelve months to the most recent quarter.
HOMRE Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 19.99 | 19.99 | 19.99 | 19.99 | 19.99 | 19.99 | 19.99 | 19.99 | 19.99 | 19.99 |
| Reserves | -17.42 | -20.76 | -15.51 | -15.19 | -16.63 | -19.14 | -19.33 | -19.77 | -19.69 | -19.70 |
| Borrowings | 44.57 | 17.87 | 2.37 | 1.32 | 1.56 | 1.56 | 1.54 | 1.47 | 3.06 | 2.96 |
| Other liabilities | 4.68 | 3.57 | 3.37 | 3.70 | 2.27 | 2.51 | 2.72 | 3.24 | 0.39 | 0.90 |
| Total liabilities | 51.82 | 20.67 | 10.22 | 9.82 | 7.19 | 4.92 | 4.92 | 4.93 | 3.75 | 4.15 |
| Fixed assets | 23.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.53 | 0.70 |
| CWIP | 3.49 | 1.12 | 1.12 | 1.12 | 1.12 | 1.12 | 1.12 | 1.12 | 1.12 | 1.31 |
| Investments | 2.95 | 2.95 | 2.95 | 2.45 | 2.45 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 |
| Other assets | 21.94 | 16.60 | 6.15 | 6.25 | 3.62 | 3.63 | 3.63 | 3.64 | 1.93 | 1.97 |
| Total assets | 51.82 | 20.67 | 10.22 | 9.82 | 7.19 | 4.92 | 4.92 | 4.93 | 3.75 | 4.15 |
As reported by the company. Total assets equal total liabilities by construction.
HOMRE Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 2.87 | 3.23 | 15.49 | 15.49 | -1.09 | -2.29 | -0.01 | 0.07 | -1.07 | 0.70 |
| Cash from investing | -3.30 | 23.45 | 0.01 | 0.01 | 1.20 | 2.29 | 0.01 | 0.00 | -0.53 | -0.37 |
| Cash from financing | 0.46 | -26.70 | -15.50 | -15.50 | 0.00 | 0.00 | 0.00 | -0.07 | 1.60 | -0.11 |
| Net cash flow | 0.03 | -0.02 | 0.00 | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.23 |
| Free cash flow | -0.45 | 26.67 | 15.49 | 15.49 | -1.09 | -2.29 | -0.01 | 0.07 | -1.60 | 0.33 |
| CFO / operating profit | -1,305% | -1,292% | -8,606% | -3,602% | 352% | 996% | 5% | -27% | 255% | 100% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
HOMRE Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | -1.13% | -0.75% | -1.42% | -6.48% | -5.07% | -6.00% | -8.24% | -12.85% | 9.11% | 36.91% |
| Debtor days | — | — | — | — | — | — | — | — | — | 26.26 |
| Inventory days | — | — | — | — | — | — | — | — | — | 0.00 |
| Cash conversion cycle | — | — | — | — | — | — | — | — | — | 26.26 |
| Working capital days | — | — | — | — | — | — | — | — | — | -55.86 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
HOMRE Ltd shareholding pattern
Promoters held 64.99% at Jun 2026, down from 67.62% at Jun 2025. FIIs 0.23% and DIIs 0.10%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 67.62% | 67.62% | 67.62% | 67.62% | 67.62% | 67.45% | 65.73% | 64.99% |
| FIIs | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% |
| DIIs | 0.10% | 0.10% | 0.10% | 0.10% | 0.10% | 0.10% | 0.10% | 0.10% |
| Public | 32.06% | 32.04% | 32.05% | 32.04% | 32.04% | 32.23% | 33.94% | 34.68% |
| No. of shareholders | 19,406 | 19,525 | 19,468 | 19,409 | 19,334 | 21,282 | 22,557 | 23,456 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When is HOMRE Ltd’s next results date?
HOMRE Ltd’s next results are scheduled for 16 Oct 2026.
- Board meetingApproval of unaudited financial results for Q2 and H1 ended September 30, 2026
See the full results calendar for every Indian company reporting in the next 30 days.
HOMRE Ltd corporate filings
- HOMRE LIMITED to announce unaudited financial results for Q2 FY2027 on October 16, 2026, with a focus on quarterly and half-yearly performanceBoard Meetinglow impact
Cruxal's analysis: HOMRE LIMITED has scheduled a board meeting on October 16, 2026, to approve and record…
Read the full analysis - In response to the email dated 29.09.2026 received from BSE, we are enclosing herewith the clarification regarding the delay,along with the revised proceedings of the 36th Annual General ....AGM/EGMmedium impact
- Intimation of Closure of Trading WindowInsider Trading / SASTlow impact
- Homre Limited Concludes 36th AGM; Approves Preferential Issue of 5.41 Crore Warrants and ESOP SchemeAGM/EGMhigh impact
Cruxal's analysis: Homre Limited has successfully concluded its 36th Annual General Meeting, where…
Read the full analysis - Homre Limited Announces Preferential Issue of 5.41 Crore Warrants and ESOP Plan 2026 at 36th AGMAGM/EGMhigh impact
Cruxal's analysis: Homre Limited has concluded its 36th Annual General Meeting, where shareholders…
Read the full analysis - Homre Limited announces change in Company Secretary and Compliance OfficerOtherslow impact
Cruxal's analysis: Homre Limited has formally announced the resignation of Ms. Pratibha Sharma from the…
Read the full analysis - Homre Limited appoints Mr. Karam Vir Singh as Company Secretary and Compliance OfficerCompany Updatelow impact
Cruxal's analysis: Homre Limited has formally announced the appointment of Mr. Karam Vir Singh as the…
Read the full analysis - Homre Limited announces resignation of Company Secretary and Compliance OfficerCompany Updatelow impact
Cruxal's analysis: Homre Limited has formally intimated the resignation of Ms. Pratibha Sharma from her…
Read the full analysis - Homre Limited Announces 36th Annual General Meeting (AGM) Scheduled for September 24, 2026Company Updatelow impact
Cruxal's analysis: Homre Limited has formally notified the BSE regarding the electronic dispatch of its…
Read the full analysis - HOMRE Ltd files revised Regulation 34(1) Annual ReportOtherslow impact
Cruxal's analysis: HOMRE Ltd has submitted a revised version of its Annual Report under Regulation 34(1) of…
Read the full analysis - HOMRE Ltd announces book closure for upcoming corporate eventCorp. Actionlow impact
Cruxal's analysis: HOMRE Ltd has issued an intimation regarding the closure of its register of members and…
Read the full analysis - HOMRE Ltd files Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: HOMRE Ltd has submitted its Annual Report for the financial year 2025-26 in compliance…
Read the full analysis - Homre Limited Announces Preferential Issue of 5.41 Crore Warrants and Adoption of ESOP 2026AGM/EGMhigh impact
Cruxal's analysis: Homre Limited has announced a preferential issue of 5.41 crore fully convertible warrants…
Read the full analysis - HOMRE Ltd submits newspaper clippings for 36th Annual General MeetingCompany Updatelow impact
Cruxal's analysis: HOMRE Ltd has submitted the required newspaper clippings regarding the notice of its 36th…
Read the full analysis - Homre Limited Announces Preferential Issue of 5.41 Crore Convertible Warrants to Raise 12.50 Crore INRCompany Updatemedium impact
Cruxal's analysis: Homre Limited has announced a preferential issue of 5.41 crore fully convertible warrants…
Read the full analysis - Homre Limited Announces Preferential Issue of Warrants worth 12.50 crore and New ESOP SchemeBoard Meetinghigh impact
Cruxal's analysis: Homre Limited has approved a preferential issue of fully convertible warrants for an…
Read the full analysis - HOMRE Limited announces board meeting to consider ESOP 2026 and preferential issue of fully convertible warrantsBoard Meetingmedium impact
Cruxal's analysis: HOMRE Limited has scheduled a board meeting for August 19, 2026, to deliberate on the…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.